RxDoctor Payments Data

Brandon Larson, OD

Optometrist · Maple Grove, MNNPI 1831453455

Payments from drug & device makers

$926in general payments, 2019–2025

Across 32 payments — averaging $28.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$246
  • Alcon$209
  • Sight Sciences, Inc.$159
  • Coopervision Inc.$118
  • Glaukos Corporation$115
  • AbbVie$30
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$926100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson Vision Care, Inc.10$246
Alcon12$209
Sight Sciences, Inc.2$159
Coopervision Inc.3$118
Glaukos Corporation1$115
AbbVie1$30
The Cameron-ehlen Group, Inc.1$18
Oyster Point Pharma, Inc.1$16
Novartis1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$926 in reported general payments places this provider in the 75th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$2,382
Medicare patients
18
Services billed
207

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost43$608
Timolol Maleate16$209

Paid to pharmacies, not to this prescriber.

Other optometrist in Maple Grove

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →